GGrantIndex
Sort

78,016 grants matching breast cancer

Drug Development for Prostate Cancer and other Metastatic Processes

$624,197
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Risk Prediction for ER Negative Breast Cancer Recurrence

$624,192
Melissa L Bondy · Baylor College Of Medicine · R01 · FY2015 · CA

Epidemiologic Architedure of Lung Cancer and Smoking

$624,146
Christopher I. Amos · Dartmouth College · U19 · FY2012 · CA

Shear stress, endothelial miRNAs, and AV calcification

$624,123
Hanjoong Jo · Emory University · R01 · FY2021 · HL

Integrative signaling models to decipher complex cancer phenotypes

$624,117
Andrea Hope Bild · University Of Utah · U01 · FY2012 · CA

A tissue viability imaging biomarker for use in non-invasive breast cancer therapy

$624,068
Allison Payne · University Of Utah · R01 · FY2023 · CA

Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention

$624,067
Adetunji T Toriola · Washington University · R37 · FY2021 · CA

Prevention of paclitaxel-induced peripheral neuropathy with nilotinib

$624,048
Maryam B. Lustberg · Ohio State University · R01 · FY2019 · CA

EZH2 LYSINE METHYLATION OF P38 MAPK SIGNALS DEADLY METASTATIC TRIPLE-NEGATIVE BREAST CANCER

$624,000
Regents Of The University Of Michigan · · FY2019 · Defense Health Agency

Biomarker and Phenotypic Risk Factors for Breast Cancer Lymphedema

$623,978
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2020 · CA

Development of Pirenzepine for CIPN

$623,955
Andrew Mizisin · Winsantor, Inc. · R42 · FY2018 · CA

A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial

$623,929
Tamara J Somers · Duke University · R01 · FY2023 · CA

Integrative approach to heterogeneity in breast cancer metastasis

$623,888
Zena Werb · University Of California, San Francisco · U01 · FY2018 · CA

Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)

$623,822
Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance

$623,782
Lance L Munn · Massachusetts General Hospital · U01 · FY2021 · CA

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance

$623,782
Lance L Munn · Massachusetts General Hospital · U01 · FY2025 · CA

Fit2ThriveMIND: Optimizing a mHealth Physical Activity Intervention with Mindful Awareness Lessons in Breast Cancer Survivors

$623,779
Siobhan Marie Phillips · Northwestern University At Chicago · R01 · FY2024 · CA

Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?

$623,747
Jeanne Mandelblatt · Georgetown University · R01 · FY2011 · CA

Increasing Colorectal and Breast Cancer Screnning in Women

$623,728
Victoria L Champion · Indiana University Indianapolis · R01 · FY2011 · CA

Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions

$623,707
David Spiegel · Stanford University · U01 · FY2017 · CA

African American Resilience in Surviving Cancer

$623,695
Felicity Harper · Wayne State University · R01 · FY2020 · CA

African American Resilience in Surviving Cancer

$623,694
Felicity Harper · Wayne State University · R01 · FY2021 · CA

African American Resilience in Surviving Cancer

$623,694
Felicity Harper · Wayne State University · R01 · FY2019 · CA

Sleep Disturbance, Inflammation, and Cellular Aging in Breast Cancer Survivors

$623,679
Michael R Irwin · University Of California Los Angeles · R01 · FY2020 · CA

TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM

$623,676
Toledo Community Hospital Oncology Prog · U10 · FY2003 · CA